IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I11A255

Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report

Javier Molina-Martin de Nicolas, MD; Didier Tchetche*, MD; Bruno Farah, MD

An 87-year-old female was admitted for symptomatic failure of a 23 mm Carpentier-Edwards PERIMOUNT aortic bioprosthesis (Edwards Lifesciences, Irvine, CA, USA) implanted 17 years previously. Both severe central regurgitation and severe stenosis (mean gradient 60 mmHg) were identified. Due to a significant perioperative risk of redo surgery (EuroSCORE 46.5%, STS 7.3%), the Heart Team decided on transfemoral valve-in-valve (ViV) implantation. A 23 mm Edwards SAPIEN 3 (S3) device (Edwards Lifesciences) was chosen, based on a measured inner diameter of 20.5 mm by multislice computed tomography (MSCT) and of 21 mm as reported by the manufacturer. The ViV procedure was performed under conscious sedation and fluoroscopy guidance. The central radiopaque marker of the S3 was positioned 1 mm above the basal ring of the PERIMOUNT, aligning the top of the S3 with the top of the failing bioprosthesis. Adequate anchoring was achieved without any coronary obstruction and trivial periprosthetic regurgitation (panel A-panel D, Moving image 1-Moving image 5). Post-procedure MSCT confirmed the proper placement of the S3 within the failed PERIMOUNT (panel E). Discharge mean transprosthetic gradient was 25 mmHg (panel F, panel G). Two months later, the patient was in NYHA Class II and the mean transprosthetic gradient had dropped to 15 mmHg.

Post-procedural mean gradients greater than 20 mmHg remain frequent in ViV for failed bioprostheses with inner diameters smaller than 21 mm. The external cuff of the S3 could provide additional constraints to the stent frame within the failed device generating high gradients. A SAPIEN XT transcatheter heart valve (Edwards Lifesciences) may still be appropriate. However, an accurate positioning will be facilitated by the S3 central marker.

Conflict of interest statement

D. Tchetche is proctor for Edwards Lifesciences, Medtronic and Boston Scientific. The other authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Ascendant aortic angiogram showing severe aortic regurgitation with a pigtail drop into the left ventricle.

Moving image 2. Angiographic view of S3 positioning.

Moving image 3. Angiographic view of S3 deployment under rapid ventricular pacing.

Moving image 4. Angiographic view of S3 post dilatation.

Moving image 5. Final ViV angiographic result with trivial periprosthetic regurgitation.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Ascendant aortic angiogram showing severe aortic regurgitation with a pigtail drop into the left ventricle.

Moving image 2. Angiographic view of S3 positioning.

Moving image 3. Angiographic view of S3 deployment under rapid ventricular pacing.

Moving image 4. Angiographic view of S3 post dilatation.

Moving image 5. Final ViV angiographic result with trivial periprosthetic regurgitation.

Volume 11 Number 11
Feb 12, 2016
Volume 11 Number 11
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV11I5A116 Sep 22, 2015
CoreValve Evolut R implantation as valve-in-valve in an Edwards SAPIEN 3 to treat paravalvular regurgitation
Bruschi G et al
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00578 Mar 20, 2018
Valve-in-valve transcatheter aortic valve implantation into a novel, sutureless bioprosthesis: technical considerations
Andreas M et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M02_06 Jul 20, 2015
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem NM et al
free
Trending articles
309.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved